RT Journal Article
T1 The Role of Citicoline and Coenzyme Q10 in Retinal Pathology
A1 García López, Claudia
A1 García López, Verónica
A1 Matamoros Felipe, José Antonio
A1 Fernández Albarral, José
A1 García Martín, Elena Salobrar
A1 Hoz Montañana, María Rosa De
A1 López Cuenca, Inés
A1 Sánchez-Puebla Fernández, Lidia
A1 Ramírez Sebastian, Jose Manuel
A1 Ramírez Sebastián, Ana Isabel
A1 Salazar Corral, Juan José
AB Ocular neurodegenerative diseases such as glaucoma, diabetic retinopathy, and age-related macular degeneration are common retinal diseases responsible for most of the blindness causes in the working-age and elderly populations in developed countries. Many of the current treatments used in these pathologies fail to stop or slow the progression of the disease. Therefore, other types of treatments with neuroprotective characteristics may be necessary to allow a more satisfactory management of the disease. Citicoline and coenzyme Q10 are molecules that have neuroprotective, antioxidant, and anti-inflammatory properties, and their use could have a beneficial effect in ocular neurodegenerative pathologies. This review provides a compilation, mainly from the last 10 years, of the main studies that have been published on the use of these drugs in these neurodegenerative diseases of the retina, analyzing the usefulness of these drugs in these pathologies.
PB MDPI
SN 1422-0067
YR 2023
FD 2023-03-07
LK https://hdl.handle.net/20.500.14352/73089
UL https://hdl.handle.net/20.500.14352/73089
LA eng
NO García López, C., García López, V., Matamoros, J. A. et al. «The Role of Citicoline and Coenzyme Q10 in Retinal Pathology». International Journal of Molecular Sciences, vol. 24, n.o 6, marzo de 2023, p. 5072. DOI.org (Crossref), https://doi.org/10.3390/ijms24065072.
NO This article belongs to the Special Issue Advances in Ocular Pharmacology and Therapeutics
NO Universidad Complutense de Madrid
NO Visufarma España
DS Docta Complutense
RD 17 ago 2024